Literature DB >> 6371226

Relaxation therapy for essential hypertension: specific or nonspecific effects?

T A Wadden.   

Abstract

This study investigated the role of nonspecific treatment factors in the behavioral control of essential hypertension. Forty-eight subjects with mild hypertension were randomly assigned to one of three conditions: (1) subject-alone relaxation therapy; (2) couples-relaxation therapy; or (3) couples-cognitive therapy. The third condition, which provided instruction in cognitive methods of stress reduction, controlled for the effects of positive treatment expectancy and other nonspecific factors. At the end of 8 weeks, subjects in all three conditions showed significant reductions in systolic and diastolic blood pressure, which were maintained at 1 and 5 months post-treatment. However, no significant differences in effectiveness were observed among conditions at any assessment period. Although the results of this study did not unequivocally demonstrate that a positive treatment expectancy is a sufficient condition for blood pressure reduction, they do raise questions concerning whether relaxation therapy is a necessary condition.

Entities:  

Mesh:

Year:  1984        PMID: 6371226     DOI: 10.1016/0022-3999(84)90040-0

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  3 in total

1.  An intervention study targeting energy and nutrient intake in worksite cafeterias.

Authors:  Michael R Lowe; Karyn A Tappe; Meghan L Butryn; Rachel A Annunziato; Maria C Coletta; Christopher N Ochner; Barbara J Rolls
Journal:  Eat Behav       Date:  2010-01-15

2.  An incremental model to isolate specific effects of behavioral treatments in essential hypertension.

Authors:  M Goebel; G W Viol; C Orebaugh
Journal:  Biofeedback Self Regul       Date:  1993-12

3.  Meal replacements, reduced energy density eating, and weight loss maintenance in primary care patients: a randomized controlled trial.

Authors:  Michael R Lowe; Meghan L Butryn; J Graham Thomas; Maria Coletta
Journal:  Obesity (Silver Spring)       Date:  2013-09-23       Impact factor: 5.002

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.